phase 1_completion
saveMAXVAX Biotechnology Co Ltd — MKK-900 (Phase I Trial Completion)
community read0 votes
Therapy area: Infectious Disease. Indication: Respiratory Syncytial Virus (RSV) Infections
Therapy area: Infectious Disease. Indication: Respiratory Syncytial Virus (RSV) Infections